Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
1,625
-248
-13% -$29K 0.14% 165
2026
Q1
$225K Sell
1,873
-61
-3% -$7.04K 0.16% 139
2025
Q4
$204K Buy
+1,934
New +$182K 0.18% 130

Other funds holding MRK

Tannin Capital's MRK Position: Q2 2026 in Review

Tannin Capital reduced its Merck (MRK) stake by 13% in Q2 2026, selling an estimated $29K and leaving 1,625 shares worth $209K. The position accounts for 0.14% of the portfolio, ranked #165.

Tannin Capital first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $225K in Q1 2026. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tannin Capital held 1,625 shares of Merck worth $209K as of Q2 2026.
  • Tannin Capital sold 248 Merck shares in Q2 2026, an estimated $29K.
  • Merck made up 0.14% of Tannin Capital's portfolio in Q2 2026, its #165 holding.
  • Tannin Capital first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Tannin Capital's Merck position peaked at $225K in Q1 2026.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tannin Capital's 13F filing for Q2 2026, filed 4 Aug 2026.